Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Early diagnosis and lifelong zinc supplementation are crucial for treating acrodermatitis enteropathica effectively.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Acitretin treatment unexpectedly darkened a patient's gray hair.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Different treatments for alopecia areata have unpredictable results and varying success rates.

In a Tuscan pediatric clinic, 7.19% of children had hair or scalp disorders, with nonscarring alopecia being the most common.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

COVID-19 can cause various skin issues, but long-term skin problems are rare.